Analysis from Pivotal Phase 3 Trial underscores impact of ... - PressZoom (press release)
February 6, 2007| Analysis from Pivotal Phase 3 Trial underscores impact of ... PressZoom (press release), Netherlands - Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ... |
AtheroGenics Announces Promotion of Charles A. Deignan to Vice ... - Genetic Engineering News (press release)
February 6, 2007| AtheroGenics Announces Promotion of Charles A. Deignan to Vice ... Genetic Engineering News (press release), NY - ... of novel drugs for the treatment of chronic inflammatory diseases, including heart disease (atherosclerosis), rheumatoid arthritis and asthma. ... |
Samaritan Pharma Aims At SP-6300 as New Innovative Treatment for ... - PharmaLive.com (press release)
February 6, 2007| Samaritan Pharma Aims At SP-6300 as New Innovative Treatment for ... PharmaLive.com (press release), PA - Long-term (chronic) use of corticosteroid medications, for the treatment of conditions such as lupus, asthma, and rheumatoid arthritis, is the most common ... |
4SC Receives Patent on Rheumatoid Arthritis Candidate - Genetic Engineering News (press release)
February 6, 2007| 4SC Receives Patent on Rheumatoid Arthritis Candidate Genetic Engineering News (press release), NY - In addition, the patent also covers further back-up substances related to SC12267, medical formulations, and the treatment of patients with SC12267. ... 4SC Granted US Patent for Drug Candidate SC12267 |
Opexa Announces Encouraging Clinical Data on Novel T-Cell ... - DG News
February 6, 2007| Opexa Announces Encouraging Clinical Data on Novel T-Cell ... DG News - Spending in the US on the treatment of rheumatoid arthritis is projected to grow to $9.5 billion annually by 2013, according to Decision Resources, ... |
AtheroGenics Announces Promotion of Charles A. Deignan to Vice ... - Market Wire (press release)
February 6, 2007 Market Wire (press release) | AtheroGenics Announces Promotion of Charles A. Deignan to Vice ... Market Wire (press release) - ... of novel drugs for the treatment of chronic inflammatory diseases, including heart disease (atherosclerosis), rheumatoid arthritis and asthma. ... |
New data shows Abbott Labs' Humira eases psoriasis - Pharma Times (subscription)
February 6, 2007| New data shows Abbott Labs' Humira eases psoriasis Pharma Times (subscription), UK - Abbott Laboratories is celebrating the news that a second Phase III trial has found that treatment with its rheumatoid arthritis drug Humira can reduce the ... |
4SC granted US patent for drug to treat rheumatoid arthritis - News-Medical.net
February 6, 2007| 4SC granted US patent for drug to treat rheumatoid arthritis News-Medical.net, Australia - In addition, the patent also covers further back-up substances related to SC12267, medical formulations and the treatment of patients with SC12267. ... 4SC Granted US Patent for Drug Candidate SC12267 |
4SC Granted US Patent for Drug Candidate SC12267 - netPR.pl (komunikaty prasowe)
February 6, 2007| 4SC Granted US Patent for Drug Candidate SC12267 netPR.pl (komunikaty prasowe), Poland - The first project on the treatment of rheumatoid arthritis is currently undergoing clinical phase IIa. Three other product candidates are in pre-clinical ... 4SC Granted US Patent for Drug Candidate SC12267 |